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Embryonic death of Mek1-deficient mice reveals a role for this
kinase in angiogenesis in the labyrinthine region of the placenta
S. Giroux, M. Tremblay, D. Bernard, J-F. Cadrin-Girard, S. Aubry, L. Larouche,
S. Rousseau, J. Huot, J. Landry, L. Jeannotte and J. Charron
Mek is a dual-specificity kinase that activates the
extracellular-signal-regulated (Erk) mitogen-activated
protein (MAP) kinases upon agonist binding to
receptors. The Erk MAP kinase cascade is involved in
cell-fate determination in many organisms. In
mammals, this pathway is proposed to regulate cell
growth and differentiation. Genetic studies have shown
that although a single mek gene is present in
Caenorhabditis elegans, Drosophila and Xenopus, two
mek homologs, Mek1 and Mek2, are present in the
mammalian cascade. In the present study, we describe
a mutant mouse line in which the mek1 gene has been
disrupted by insertional mutagenesis. The null mutation
was recessive lethal, as the homozygous mutant
embryos died at 10.5 days of gestation.
Histopathological analyses revealed a reduction in
vascularization of the placenta that was due to a
marked decrease of vascular endothelial cells in the
labyrinthine region. The failure to establish a functional
placenta probably explains the death of the mek1–/–
embryos. Cell-migration assays indicated that mek1–/–
fibroblasts could not be induced to migrate by
fibronectin, although the levels of Mek2 protein and Erk
activation were normal. Re-expression of Mek1 in the
mutant mouse embryonic fibroblasts (MEFs) restored
their ability to migrate. Our findings provide genetic
evidence that establishes the unique role played by
Mek1 in signal transduction. They also suggest that
mek1 function is required for normal response to
angiogenic signals that might promote vascularization
of the labyrinthine region of the placenta.
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Results and discussion
A mutation in the mek1 gene was generated by random
insertional mutagenesis into embryonic stem cells using
the ROSAβ-geo promoter-trap retroviral vector [1]. One
ROSAβ-geo clone (J2), which contained a single insertion,
did not generate viable homozygous mutants when hetero-
zygous mice were intercrossed, suggesting that the muta-
tion was embryonic lethal. The integration of the
promoter-trap vector in this clone occurred in the mek1
gene without major rearrangement and generated a mek1
null allele; see Supplementary material published with this
article on the internet for a detailed analysis.
To determine the time of death of mek1–/– embryos, 9.5 to
16.5 day old (E9.5 to E16.5) embryos were genotyped. At
E9.5 and E10.5, Mendelian ratios of wild-type, hetero-
zygous and homozygous mek1 mutant embryos were
obtained (N = 114 at E9.5 and N = 116 at E10.5). At E10.5,
however, 8 of the 25 mek1–/– embryos were underdevel-
oped, while 9 were moribund or in the process of being
resorbed. At E11.5, out of 21 embryos obtained, 8 mek1–/–
embryos were found dead, indicating that the loss of mek1
function resulted in embryonic lethality at around E10.5.
In whole embryos, defects were first observed at E10.5,
when the yolk sac of mek1–/– embryos appeared pale and
apparently devoid of blood circulation (Figure 1a,b). His-
tological analysis of E10.5 mutant yolk sacs revealed few
blood cells, however, and the blood vessels appeared dis-
tended (Figure 1c,d). One third of the homozygous mutant
embryos were smaller than their wild-type and heterozy-
gous littermates, and hemorrhaging in the embryo proper
was observed in a few cases (Figure 1b), suggesting anom-
alies in blood circulation or blood vessel formation. Histo-
logical analyses did not reveal any obvious defects in the
heart of mek1–/– embryos, however (data not shown). In
addition, most of the E10.5 mek1–/– embryos exhibited
necrosis in various tissues, even though the heart was still
beating and no sign of hemorrhaging was detectable at the
time of dissection, indicating that the onset of resorption
was most likely due to pre-existing problems.
To determine if anomalies in extraembryonic tissues
accounted for the embryonic necrosis and lethality, we ana-
lyzed placentas of E9.5 and E10.5 embryos. The placentas
from mek1–/– embryos were abnormal (Figure 1e–h; data
not shown). The spongiotrophoblast layer was less defined
and the labyrinthine region appeared more compact and
had considerably fewer blood vessels (Figure 1e–h, 2e–j).
The maternal erythrocytes were located on the maternal
side of the labyrinthine area, whereas embryonic erythro-
cytes remained in the blood vessels of the allantois and the
chorion. A detailed in situ hybridization analysis of the cell
lineages of placenta supported the histological observations
(Figure 2). All the placental markers tested were expressed
in wild-type and mek1–/– embryos, indicating that the lack
of mek1 function did not perturb the normal differentiation
of the various cell lineages (Figure 2). In wild-type
embryos, however, the labyrinthine trophoblasts (detected
using a probe for the tec gene) and vascular endothelial
cells (detected using a probe for the flk-1 gene) were inter-
mingled, whereas in mek1–/– specimens the vascular
endothelial cells were mostly restricted to the chorioallan-
toic region (Figure 2g,h). Vascular endothelial cells were
therefore produced in mek1–/– embryos but seemed unable
to efficiently invade the labyrinthine region, suggesting a
defect in angiogenesis. Whole-mount in situ hybridization
with a probe (flt-1) for the vascular endothelial growth
factor (VEGF) receptor showed that vasculogenesis pro-
ceeded normally in mek1–/– embryos (Figure 2k–m) [2].
Staining of intersomitic vessels and capillaries in the head
region suggested that the absence of mek1 function did not
significantly prevent embryonic vasculogenesis or early
angiogenic processes [3,4].
The Erk cascade has been shown to be involved in hapto-
taxis — cell migration induced by the extracellular matrix
(ECM) — as well as in angiogenesis [5,6]. A possible
explanation for the failure of endothelial cells to effi-
ciently invade the labyrinthine layer of the placenta of
mek1–/– mutants is that mek1–/– cells are impaired in their
ability to migrate. Wild-type and mek1–/– MEF cell lines
were derived from E9.5 embryos and tested in a transfilter
haptotaxis assay [5]. When collagen was used as a sub-
strate, wild-type and mek1–/– MEFs showed similar motil-
ity (Figure 3a). In contrast, cell migration induced by
fibronectin was greatly reduced in mutant MEFs. The
failure of mek1–/– fibroblasts to migrate was not due to a
defect in cell adhesion, because no major difference in
attachment and spreading on ECM was observed between
the two cell lines (Figure 3b; data not shown). The cell
migration defect observed in mek1 mutant cells might be
caused by a lack of Erk activation, because cell migration
induced by ECM and angiogenesis is associated with acti-
vation of this cascade [5,6]. We analyzed the activation of
Erk by mobility shift assay and kinase activity assay when
quiescent wild-type and mek1–/– MEFs were seeded on
fibronectin. Erk activation appeared to proceed normally
in mek1–/– MEFs (Figure 3c; data not shown). This surpris-
ing finding may be explained by the presence of normal
levels of Mek2 in mek1–/– MEFs.
To confirm that mek1 function is required for haptotaxis,
wild-type and mek1–/– MEFs were transfected with a mek1
expression vector. Individual clones or pools of stable
transfectants were isolated and migratory properties of
each sample on fibronectin were examined. As shown in
Figure 3d, migration was restored by expression of mek1 in
pools of stable transfectants and in individual clones, but
not by transfection with empty vector. Restoration of
migration also appeared to directly correlate with the level
of Mek1 protein produced in the individual clones. In the
pool of clones, migration was probably only partially
restored because only 20% of the cells expressed Mek1
(this figure is an estimate based on the number of individ-
ual Mek1-expressing clones obtained). As the Mek2
protein level was normal in mek1–/– MEFs, our rescue
experiments indicated that Mek1 was essential for the
correct signal transduction required in haptotaxis induced
by fibronectin, but not that induced by collagen.
Recent work of Eliceiri et al. [6] has shown that the Erk
cascade is involved in both angiogenesis and cell migra-
tion of vascular endothelial cells and that the sustained
activation of Erk MAP kinase by integrin αvβ3 is neces-
sary for angiogenesis. When wild-type MEFs were pre-
incubated with an anti-αvβ3 antibody [6], we observed
that fibronectin-induced cell migration was blocked,
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Figure 1
Morphological and histological analyses of mek1–/– embryos. Whole-
mount views of E10.5 (a) wild-type (+/+) and (b) mek1–/– (–/–) yolk
sacs showing a reduction in the number of blood cells in mek1 mutant
yolk sacs. Hematoxylin and eosin staining of E10.5 (c) wild-type and
(d) mek1–/– yolk sac sections showing the presence of fewer blood
cells, and distended blood vessels in mutant specimens. Hematoxylin
and eosin staining of E9.5 (e) wild-type and (f) mek1–/– placenta
sections showing a lack of embryonic blood vessels in the labyrinthine
region of mutant placentas. Higher magnifications of the boxed regions
in (e,f) are shown in (g,h), respectively. Abbreviations: al, allantois; ec,
endothelial cells; ee, embryonic erythrocytes; en, endoderm; g, giant
cells; l, labyrinthine region; m, mesoderm; me, maternal erythrocytes; s,
spongiotrophoblast cells. Scale bar represents 0.1 mm.
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whereas no inhibition occurred when an anti-αvβ5 mono-
clonal antibody was used (Figure 3e). As was shown for
cell attachment to fibronectin, the inability of MEFs to
migrate in the haptotaxis assay was not caused by a defect
in cell adhesion (Figure 3f). Altogether, these results sug-
gested that cell migration requires the αvβ3 signaling
cascade and that, in the absence of Mek1, this pathway
may be defective and thereby contribute to the impaired
angiogenesis observed for the vascular endothelial cells in
mutant embryos.
Our study establishes an essential role for Mek1 in pla-
cental development. By contrast, we found no clear phe-
notype in the mek1–/– embryos before midgestation. This
suggests both that Mek1 has a specific role in signal trans-
duction and that there is a partial complementation of
mek1 function by mek2. The specificity of Mek1 action
could be achieved through differential expression of mek1
and mek2 genes in particular tissues. This seems unlikely,
however, because both genes are widely expressed in
wild-type embryonic and extraembryonic tissues at the
time of death of the mek1 mutant embryos (see Supple-
mentary material). Moreover, the presence of Mek2 is not
sufficient to compensate for the lack of Mek1 in mek1–/–
MEFs. Alternatively, it is possible that, although some
ligands can use either Mek1 or Mek2 to transduce signals,
others might require specific components of the Erk
MAP kinase cascade. The two Mek isoforms may be
recruited by distinct protein complexes involved in spe-
cific responses by scaffolding/adaptor proteins as in yeast
[7]. Such proteins have been identified in mammals [8,9].
In some cases, however, Mek2 or another kinase might
replace Mek1, similar to the situation in yeast where, in
the absence of Fus3p, Kss1p can participate in the
protein complex involved in the pheromone response [7].
Some preliminary results support this hypothesis. For
instance, activation of Erk by bombesin was dependent
on Mek1 and sensitive to the Mek1 inhibitor PD098059
in wild-type MEF cells as reported for Swiss 3T3 cells
[10]. In mek1–/– MEFs, however, Erk activation still
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Figure 2
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Expression of cell-type specific markers in the placenta. Near adjacent
sections of E9.5 (a,c,e,g,i) wild-type (+/+) and (b,d,f,h,j) mek1–/– (–/–)
placentas were used in in situ hybridization experiments with specific
placental cell markers: (a,b) mouse placental lactogen, mPL1
(secondary giant cells); (c,d) 4311 (spongiotrophoblasts); (e–h) VEGF
receptor, flk-1 (vascular endothelial cells); and (i,j) tec (labyrinthine
trophoblasts) [2,11]. Higher magnifications of the boxed areas from (e)
and (f) are shown in (g,h), respectively. (k–m) Whole-mount in situ
hybridization of flt-1 expression in E9.5 wild-type and mek1–/–
embryos. Expression of flt-1 was widely detected in the whole
embryo, with no major difference in the network of blood vessels
between (k) wild-type and (l,m) mek1–/– embryos. Abbreviations: al,
allantois; gl, giant cell layer; iv, intersomitic vessels; l, labyrinthine
region; lt, labyrinthine trophoblasts; s, spongiotrophoblast cells; vec,
vascular endothelial cells. Scale bar represents 0.1 mm in (a–j) and
0.5 mm in (k–m).
occurred but became resistant to PD098059, suggesting
the participation of other kinase(s) (M.T. and J.C.,
unpublished observations).
Supplementary material
Additional data, including sequence and organisation of the disrupted
mek1 gene, characterization of the mek1 mutant allele, mek1 and
mek2 gene expression in the developing embryo and methodological
details are published with this paper on the internet.
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Figure 3
Migration properties of wild-type, mek1–/– and
mek1-transfected MEFs. (a) Wild-type (+/+)
and mutant (–/–) MEFs were serum-starved
for 24 h and allowed to migrate for 2 h across
a polycarbonate membrane coated with either
BSA (control), collagen (10 µg/ml) or
fibronectin (10 µg/ml) in a modified Boyden
chamber. The results shown are a
representative experiment from three
independent experiments. (b) Phase-contrast
images of wild-type or mek1–/– serum-starved
MEFs 90 min after seeding on plates coated
with BSA (control), collagen or fibronectin.
Magnification, 200×. (c) Quiescent MEFs
were kept in suspension (Sus) or plated on
petri dishes coated with 10 µg/ml fibronectin
(Fn) and incubated for 30 and 60 min at
37°C. The control samples were plated on
fibronectin in the presence of 20% fetal calf
serum (FCS) and incubated for 20 min at
37°C. After incubation, Erk2 phosphorylation
was evaluated by mobility shift assay (Erk2-P
represents the phosphorylated form of Erk2).
The results shown are a representative
experiment from three independent
experiments. (d) Wild-type and mek1–/– MEFs
transfected with an empty expression vector
or the mek1 cDNA expression vector were
isolated as pool of approximately 100 clones
or as individual clones, and used in haptotaxis
assays. Pools of clones and individual clones
were allowed to migrate for 2 h and 4 h,
respectively. Representative results from two
separate experiments are shown. The level of
Mek1 protein in the transfectants was
determined by western blot analysis.
(e) Haptotaxis of wild-type MEFs induced by
fibronectin can be blocked by anti-αvβ3
antibodies. Wild-type MEFs were serum-
starved for 24 h and allowed to migrate for 2 h
across a polycarbonate membrane coated
with fibronectin after incubation with blocking
antibodies against integrins αvβ3 or αvβ5 or
without incubation with blocking antibodies
(control). (f) Phase-contrast images of wild-
type serum-starved MEFs seeded on
fibronectin-coated plates for 90 min after
incubation with antibodies against the
integrins αvβ3 or αvβ5 or without anti-integrin
antibodies (control). Magnification, 200×.
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Supplementary results and discussion
Characterization of the mek1 mutant allele in the ROSAβ-
geo-J2 mouse line
Integration of the ROSAβ-geo vector generated a fusion
gene, the transcript of which was cloned using the rapid
amplification of cDNA 5′ ends (5′ RACE) method, and
comparison to databases revealed that the integration had
disrupted the mek1 gene (Figure S1). As expected for
retroviral integration, no major rearrangement was associ-
ated with the integration (Figure S2). The vector had
inserted into a 20 kb KpnI fragment that hybridized with a
probe located downstream of the insertion site (probe C)
and generated a new 15 kb KpnI band. Probes derived
from sequences located upstream and downstream of the
insertion (probes B and D) detected only endogenous
genomic mek1 fragments. Therefore, the only gene dis-
rupted by the insertion was the mek1 gene. 
Insertion into the mek1 locus is predicted to interrupt the
transcription of the mek1 gene after codon 26 (Figure S1).
To confirm that the insertion generated a null allele, we
performed western blot analyses using an antibody
directed against the amino terminus of Mek1 [S1] in E10.5
embryos and in established MEFs. Mek1 protein was
detected in extracts from wild-type and heterozygous
embryos and MEFs but not in homozygous mutant
embryos and MEFs (Figure S3; data not shown). The same
result was obtained with an antibody against the Mek1 car-
boxyl terminus [S2], establishing that no full-length or
truncated Mek1 protein was produced (data not shown).
Western blot analysis using an antibody against Mek2 was
also performed. Mek2 protein was present in all embryonic
and MEF samples regardless of their genotype and no vari-
ation in the level of Mek2 between wild-type and mek1–/–
samples was observed, suggesting no compensation by
Supplementary material
Figure S1
Sequences of the ROSAβ-geo-J2 fusion
cDNA and comparison with the mouse mek1
gene. The boxed sequences corresponded to
the 5′ primer sequence and the splice
acceptor sequence of the promoter trap
vector. Interruption of homology in 3′ of the
RACE product coincided with the splice
acceptor site of the promoter trap vector,
indicating that the insertion took place into an
intron of the mek1 gene. The 5′ sequence of
the RACE product corresponded to the 5′
untranslated region of the mek1 mRNA, as
shown by the cloning of a full-length mek1
cDNA clone from an ES cell cDNA library (the
5′ end of the cDNA is indicated by the bold
nucleotide C at position 50). The initiation
codon of mek1 is underlined.
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overexpression of Mek2 (Figure S3; data not shown) [S3].
These results clearly indicate that the retroviral insertion
generated a mek1 null mutation.
Expression of the mek1 and mek2 genes in the developing
embryo
To determine whether the structural defects observed in
mek1 mutant embryos correlate with the normal mek1
expression profile, we analyzed the expression of the gene
during development. We first looked at the β-galacto-
sidase staining pattern in mek1 heterozygous mutant
embryos. From E7.5 to E12.5, β-galactosidase activity was
detected throughout the embryo indicating a widespread
expression (Figure S4a; data not shown). In situ hybridiza-
tion experiments were also performed on sections from
E9.5 to E11.5 mouse embryos and placentas with RNA
probes specific for either mek1 or mek2. At these stages,
both mek1 and mek2 gene expression showed a ubiquitous
pattern in the embryo and the placenta (Figure S4b–e;
data not shown), but some differences can be observed.
For instance, mek1 was strongly expressed in the placenta,
whereas the highest level of mek2 expression was detected
in the embryo. The absence of mek1 function did not seem
to affect the pattern of mek2 expression in the placenta
(Figure S4f). It therefore appeared that the effects of the
lack of Mek1 in the placenta could not be rescued by
Mek2 expression, causing a profound perturbation of the
vascularization of the labyrinthine region. The role of
Mek1 in vascularization of the placenta may thus involve
transduction of signals specific for a Mek1 cascade.
Supplementary materials and methods
Cell culture and generation of germline chimeras 
WW6 ES cells were grown and infected with ROSAβ-geo retrovirus as
described previously [S4]. Embryos were manipulated as described
previously [S5]. Chimeric males were first bred with MF1 females to
identify germ-line transmitters by coat color. The germ-line chimeras
were then mated to 129/SvEv inbred mice to establish the promoter-
trap mouse lines.
cDNA cloning
The 5′ RACE technique was performed essentially as described by
Frohman et al. [S6]. Total RNA was extracted from E10.5 lacZ-positive
embryos using the LiCl/urea method. Poly(A) RNA was prepared from
total RNA by one-step chromatography on oligo(dT)-cellulose [S7]. The
lacZ primer (5′-TGTTGGGAAGGGCGATCGGT-3′) was used to
reverse transcribe the RNA with the Superscript II reverse transcriptase
according to the manufacturer’s instructions (Gibco BRL). Excess
primer was removed by filtration on Microcon-100 (Amicon). The
single-stranded cDNA was tailed using terminal transferase and dATP.
The anchor primer (5′-CATCGATGTCGACTCGAGTTTTTTTTTTTTT-
TTTT-3′) was used to initiate the synthesis of the second strand. The
double-stranded cDNA was then amplified for 35 cycles with 45 sec at
94°C, 45 sec at 52°C, and 1 min at 72°C using the 5′ adaptor primer
(5′-CCATCGATGTCGACTCGAG-3′), and the 3′ promoter trap primer
(5′-GATCCGCCATGTCACAGATC-3′). The PCR product was purified
S2 Supplementary material
Figure S2
Characterization of the mek1 mutated allele in the ROSAβ-geo-J2
mouse line. (a) Schematic representation of the mek1 mRNA with the
different probes (A–D) used to characterize the mek1 mutated allele.
The initiation and termination codons are indicated. (b) Southern blot
analysis of yolk sac DNAs isolated from E10.5 wild-type (+/+),
heterozygous (+/–) and homozygous (–/–) mek1 mutant embryos. Yolk
sac DNA was digested with KpnI, blotted, and hybridized with the
various mek1 cDNA probes indicated. Lane M contained the molecular
size marker λ HindIII (23.1, 9.4, 6.6 kb from top to bottom).
(c) Schematic diagram of the organization of the mek1 gene at the site
of insertion. The arrows indicate the positions of the KpnI sites. 
ROSAβ-geo
20 kb10 kb 10 kb
15 kb
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Figure S3
Disruption of the mek1 gene in the ROSAβ-geo-J2 mouse line
generated a null allele. Proteins were extracted from E10.5 wild-type
(+/+), heterozygous (+/–) and homozygous (–/–) mek1 mutant
embryos to determine the presence of Mek1 (upper panel) and Mek2
(lower panel) proteins by western analysis.
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Mek2
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by agarose gel electrophoresis and cloned in BlueScript vector (Strata-
gene). The 5′ RACE product was also used as probe to screen an ES-
cell cDNA library to obtain a full-length mek1 cDNA [S8].
β-galactosidase staining and RNA in situ hybridization analyses
β-galactosidase staining was performed as described [4]. The whole-
mount in situ hybridization protocol was based on that described in
Wilkinson and Nieto [S9]; radioactive in situ hybridization on tissue
sections has been described [S10]. The following murine fragments
were used as templates for synthesizing either digoxigenin or
[35S]UTP-labeled riboprobes: a 750 bp 4311 cDNA clone, a 600 bp
placental lactogen1 (mPL1) cDNA clone, a tec cDNA clone, a 1.6 kb
flt-1 cDNA clone, a 800 bp flk-1 cDNA clone, the 5′ RACE product
containing the 5′ untranslated and translated regions of the mek1
cDNA, and a 312 bp AvaI–PstI cDNA fragment corresponding to the
3′ untranslated sequences of the mek2 cDNA [S11,S12]. Bright-field
and dark-field illuminations were digitized using a DAGE-MTI model
DC330E video camera and a Scion CG7 capture board. Lower magni-
fication images were photographed using a Leica Wild M8 binocular.
Figures were processed using Adobe Photoshop 4.0 program and
printed using a Kodak DS 8650 PS printer.
Isolation of mouse embryonic fibroblasts
Intercrosses of mek1 heterozygous mutants were used to derive MEFs
from E9.5 embryos. Embryos were first dissected to remove the heart
and the head, washed in PBS, and the cells were then dissociated in
0.5% trypsin/EDTA for 5 min. Cell suspensions were seeded in 4-well
culture plates in DMEM, 10% FCS, 2 mM L-glutamine, 50 units/ml
Penicillin and 50 µg/ml Streptomycin. MEFs became established cell
lines after a few months in culture. 
Haptotaxis cell migration and adhesion assays
Cell migration was assayed using a modified Boyden chamber as
described [S13,S14]. Briefly, the underside of a 5.0 µm pore size poly-
carbonate membrane was coated for 2 h at 37°C with either 10 µg/ml
collagen type I or fibronectin prepared in PBS, rinsed once with PBS,
and then placed into the lower chamber containing 500 µl of migration
buffer (DMEM, 10 mM HEPES pH 7.4, 1.0 mM MgCl2, 0.5% BSA).
Serum-starved cells were harvested with trypsin — which was then
blocked with trypsin inhibitor — counted, centrifuged and resuspended
in migration buffer. Around 50,000–150,000 cells were used in the
migration assay. After 2 h, the number of migrated cells on the lower
face of the membrane was counted in five independent fields under
100× magnification. When anti-integrin antibodies were used, a pre-
incubation of 15 min at 37°C of wild-type MEFs with the antibody was
performed prior to the migration assay on fibronectin. Monoclonal anti-
bodies against integrins αvβ3 (clone LM609) and αvβ5 (clone P1F6)
were purchased from Chemicon International. All assays were done in
triplicate and repeated at least twice.
Adhesion assays were performed as described [S15]: 24-well tissue
culture plates were coated overnight at 4°C with either collagen type I
or fibronectin (500 µl at 100 µg/ml in PBS). Before the test, the wells
were blocked with 2% BSA in PBS at 37°C for 1 h. Serum-starved
cells were harvested as described above, except that the cells were
washed once, and suspended in DMEM supplemented with 2% BSA
before seeding in the wells. Cells were incubated for 30 or 90 min at
37°C in 5% CO2. Non-adherent cells were gently washed away twice
in PBS at room temperature, and the remaining adherent cells were
fixed in 3.7% formaldehyde in PBS at 4°C. They were examined and
photographed under a phase-contrast microscope (Leica).
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Figure S4
Expression of mek1 and mek2 in the placenta
and the embryo at E10.5. (a) X-gal staining of
a mek1 heterozygous (+/–) embryo showing
the widespread expression pattern of mek1.
Near adjacent sections of E10.5 (b,c)
embryos and (d–f) placentas were used in in
situ hybridization experiments for (b,d) mek1
expression or (c,e,f) mek2 expression. (b–e)
Wild-type (+/+); (f) mek1–/– (–/–). Both mek1
and mek2 genes are widely expressed in the
embryo, confirming the result obtained by 
X-gal staining for the mek1 gene. In the
placenta, mek1 is more strongly expressed in
the embryonic portion when compared with
the signal detected in the rest of the embryo
or placenta. Scale bar represents 0.5 mm.
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Western blot analysis and mobility shift assay
Total cell lysate (20 µg) was resolved on a denaturing 10% polyacry-
lamide gel, transferred to nitrocellulose and probed with polyclonal anti-
bodies specific for Mek1 [S16,S17], or M24520, a monoclonal
antibody specific for Mek2 (Transduction Laboratory). Antibody binding
was revealed with chemiluminescence using the LumiGlo substrate kit
(Kirkegaard and Perry Laboratories). The MAP kinase mobility shift
assay was performed as described by Chen et al. [S18], except that
the total cell lysate was electrophoresed on a 10% polyacrylamide gel
with a 150:1 acrylamide:bis-acrylamide ratio, and the Erk2 polyclonal
antibody was used to probe the western blot [S14].
Plasmid construction and fibroblast transfection
The mek1 expression vector was constructed using the pRc/RSV
plasmid (Invitrogen Corporation) using standard cloning procedures.
The PGK-Hygro selection marker was first cloned into the BglII site of
pRc/RSV to generate the pHyg/RSV selectable expression vector.
Then, the mouse mek1 cDNA was excised from pBluescriptII (Strata-
gene) as a HindIII–XbaI fragment and subcloned into the correspond-
ing sites of the pHyg/RSV vector, generating the pHyg/RSV-mek1
plasmid. Wild-type and mek1 mutant fibroblast cell lines were trans-
fected with either 5 µg pHyg/RSV or pHyg/RSV-mek1 plasmids using
the calcium-phosphate co-precipitation method. Stable transfectants
were selected in media supplemented with 400 µg/ml hygromycin.
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